Efficacy and Satisfaction With Remifentanil Analgesia in Parturients During the Childbirth
NCT ID: NCT02447757
Last Updated: 2016-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
66 participants
OBSERVATIONAL
2010-01-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Experience of Giving Birth With Remifentanil for Pain Relief: A Qualitative Study of Mothers and Midwives
NCT07030777
Remifentanil vs. Combined Spinal-epidural Analgesia for Labor Analgesia and Progress of Labor in Multiparous
NCT02963337
Patient Controlled Remifentanil Analgesia for Normal Labour
NCT04541719
Remifentanil as Intravenous Patient-controlled Analgesia (IVPCA) During Labour
NCT00202722
Continuous Remote Vital Sign Monitoring During Labour Analgesia With Remifentanil
NCT07167498
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The analgesic efficacy will be evaluated by the change in VAS (visual analogue scale) score after induction of remifentanil analgesia Satisfaction will be evaluated by the questionary.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parturients with remifentanil analgesia
Parturients after induction of remifentanyl analgesia during the delivery
remifentanil
Remifentanil analgesia during delivery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
remifentanil
Remifentanil analgesia during delivery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* administered remifentanil analgesia
* signed informed consent
Exclusion Criteria
* missing data about the analgetic method a analgetic efficacy
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Sokolov
UNKNOWN
Brno University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Petr Štourač, MD
MD, Ph.D
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
KDAR - department of pediatrics anesthesia and resuscitation
Brno, Brno, Czechia
Sokolov Hospital
Sokolov, , Czechia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KDAR Sokolov
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.